Molecular analysis of circulating tumour cells—biology and biomarkers (original) (raw)

• Schilsky, R. L. Personalized medicine in oncology: the future is now. Nat. Rev. Drug Discov. 9, 363–366 (2010).
  Article CAS PubMed Google Scholar
• McDermott, U. & Settleman, J. Personalized cancer therapy with selective kinase inhibitors: an emerging paradigm in medical oncology. J. Clin. Oncol. 27, 5650–5659 (2009).
  Article CAS PubMed Google Scholar
• Dancey, J. E., Bedard, P. L., Onetto, N. & Hudson, T. J. The genetic basis for cancer treatment decisions. Cell 148, 409–420 (2012).
  Article CAS PubMed Google Scholar
• Dienstmann, R., Rodon, J. & Tabernero, J. Biomarker-driven patient selection for early clinical trials. Curr. Opin. Oncol. 25, 305–312 (2013).
  Article CAS PubMed Google Scholar
• Shaw, A. T. et al. Crizotinib versus chemotherapy in advanced _ALK_-positive lung cancer. N. Engl. J. Med. 368, 2385–2394 (2013).
  Article CAS PubMed Google Scholar
• Zhou, C. et al. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study. Lancet Oncol. 12, 735–742 (2011).
  Article CAS PubMed Google Scholar
• Mok, T. S. et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N. Engl. J. Med. 361, 947–957 (2009).
  Article CAS PubMed Google Scholar
• Pao, W. et al. Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Med. 2, e73 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Pao, W. et al. KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib. PLoS Med. 2, e17 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Garraway, L. A. & Baselga, J. Whole-genome sequencing and cancer therapy: is too much ever enough? Cancer Discov. 2, 766–768 (2012).
  Article PubMed Google Scholar
• Gonzalez de Castro, D., Clarke, P. A., Al-Lazikani, B. & Workman, P. Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance. Clin. Pharmacol. Ther. 93, 252–259 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Misale, S. et al. Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer. Nature 486, 532–536 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Wu, C. C., Maher, M. M. & Shepard, J. A. Complications of CT-guided percutaneous needle biopsy of the chest: prevention and management. AJR Am. J. Roentgenol. 196, W678–W682 (2011).
  Article PubMed Google Scholar
• Yachida, S. et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114–1117 (2010).
  CAS PubMed PubMed Central Google Scholar
• Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883–892 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Ding, L. et al. Genome remodeling in a basal-like breast cancer metastasis and xenograft. Nature 464, 999–1005 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Nowell, P. C. The clonal evolution of tumor cell populations. Science 194, 23–28 (1976).
  Article CAS PubMed Google Scholar
• Greaves, M. F., Maia, A. T., Wiemels, J. L. & Ford, A. M. Leukemia in twins: lessons in natural history. Blood 102, 2321–2333 (2003).
  Article CAS PubMed Google Scholar
• Bateman, C. M. et al. Acquisition of genome-wide copy number alterations in monozygotic twins with acute lymphoblastic leukemia. Blood 115, 3553–3558 (2010).
  Article CAS PubMed Google Scholar
• Anderson, K. et al. Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature 469, 356–361 (2011).
  Article CAS PubMed Google Scholar
• Landau, D. A. et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 152, 714–726 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Swanton, C. Intratumor heterogeneity: evolution through space and time. Cancer Res. 72, 4875–4882 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Fidler, I. J. Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res. 38, 2651–2660 (1978).
  CAS PubMed Google Scholar
• Greaves, M. & Maley, C. C. Clonal evolution in cancer. Nature 481, 306–313 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Kim, M. Y. et al. Tumor self-seeding by circulating cancer cells. Cell 139, 1315–1326 (2009).
  Article PubMed PubMed Central Google Scholar
• Pantel, K. & Brakenhoff, R. H. Dissecting the metastatic cascade. Nat. Rev. Cancer 4, 448–456 (2004).
  Article CAS PubMed Google Scholar
• Baccelli, I. et al. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat. Biotechnol. 31, 539–544 (2013).
  Article CAS PubMed Google Scholar
• Yu, M., Stott, S., Toner, M., Maheswaran, S. & Haber, D. A. Circulating tumor cells: approaches to isolation and characterization. J. Cell Biol. 192, 373–382 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Alix-Panabières, C. & Pantel, K. Circulating tumor cells: liquid biopsy of cancer. Clin. Chem. 59, 110–118 (2013).
  Article CAS PubMed Google Scholar
• Hou, J. M. et al. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. J. Clin. Oncol. 30, 525–532 (2012).
  Article PubMed Google Scholar
• Krebs, M. G. et al. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J. Clin. Oncol. 29, 1556–1563 (2011).
  Article PubMed Google Scholar
• de Bono, J. S. et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin. Cancer Res. 14, 6302–6309 (2008).
  Article CAS PubMed Google Scholar
• Cohen, S. J. et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J. Clin. Oncol. 26, 3213–3221 (2008).
  Article PubMed Google Scholar
• Cristofanilli, M. et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N. Engl. J. Med. 351, 781–791 (2004).
  Article CAS PubMed Google Scholar
• Khan, M. S. et al. Circulating tumor cells as prognostic markers in neuroendocrine tumors. J. Clin. Oncol. 31, 365–372 (2013).
  Article CAS PubMed Google Scholar
• Khoja, L. et al. Biomarker utility of circulating tumor cells in metastatic cutaneous melanoma. J. Invest. Dermatol. 133, 1582–1590 (2013).
  Article CAS PubMed Google Scholar
• Hiraiwa, K. et al. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers. Ann. Surg. Oncol. 15, 3092–3100 (2008).
  Article PubMed Google Scholar
• Devriese, L. A., Voest, E. E., Beijnen, J. H. & Schellens, J. H. Circulating tumor cells as pharmacodynamic biomarker in early clinical oncological trials. Cancer Treat. Rev. 37, 579–589 (2011).
  Article CAS PubMed Google Scholar
• Pailler, E. et al. Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer. J. Clin. Oncol. 31, 2273–2281 (2013).
  Article PubMed Google Scholar
• Maheswaran, S. et al. Detection of mutations in EGFR in circulating lung-cancer cells. N. Engl. J. Med. 359, 366–377 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Pestrin, M. et al. Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients. Breast Cancer Res. Treat. 118, 523–530 (2009).
  Article CAS PubMed Google Scholar
• Attard, G. et al. Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer. Cancer Res. 69, 2912–2918 (2009).
  Article CAS PubMed Google Scholar
• Schneck, H. et al. Analysing the mutational status of PIK3CA in circulating tumor cells from metastatic breast cancer patients. Mol. Oncol. 7, 976–986 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, L. et al. The identification and characterization of breast cancer CTCs competent for brain metastasis. Sci. Transl. Med. 5, 180ra148 (2013).
  Article CAS Google Scholar
• Tang, F. et al. mRNA-Seq whole-transcriptome analysis of a single cell. Nat. Methods 6, 377–382 (2009).
  Article CAS PubMed Google Scholar
• Ramsköld, D. et al. Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells. Nat. Biotechnol. 30, 777–782 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Thiery, J. P. Epithelial–mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2, 442–454 (2002).
  Article CAS PubMed Google Scholar
• Thiery, J. P. & Lim, C. T. Tumor dissemination: an EMT affair. Cancer Cell 23, 272–273 (2013).
  Article CAS PubMed Google Scholar
• Tsuji, T., Ibaragi, S. & Hu, G. F. Epithelial–mesenchymal transition and cell cooperativity in metastasis. Cancer Res. 69, 7135–7139 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Tsuji, T. et al. Epithelial–mesenchymal transition induced by growth suppressor p12CDK2–AP1 promotes tumor cell local invasion but suppresses distant colony growth. Cancer Res. 68, 10377–10386 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Calbo, J. et al. A functional role for tumor cell heterogeneity in a mouse model of small cell lung cancer. Cancer Cell 19, 244–256 (2011).
  Article CAS PubMed Google Scholar
• Duda, D. G. et al. Malignant cells facilitate lung metastasis by bringing their own soil. Proc. Natl Acad. Sci. USA 107, 21677–21682 (2010).
  Article PubMed PubMed Central Google Scholar
• Friedl, P. et al. Migration of coordinated cell clusters in mesenchymal and epithelial cancer explants in vitro. Cancer Res. 55, 4557–4560 (1995).
  CAS PubMed Google Scholar
• Bednarz-Knoll, N., Alix-Panabières, C. & Pantel, K. Clinical relevance and biology of circulating tumor cells. Breast Cancer Res. 13, 228 (2011).
  Article PubMed PubMed Central Google Scholar
• Vona, G. et al. Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulating tumor cells. Am. J. Pathol. 156, 57–63 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Müller, V. et al. Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity. Clin. Cancer Res. 11, 3678–3685 (2005).
  Article PubMed Google Scholar
• Gascoyne, P. R., Noshari, J., Anderson, T. J. & Becker, F. F. Isolation of rare cells from cell mixtures by dielectrophoresis. Electrophoresis 30, 1388–1398 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Moon, H. S. et al. Continuous separation of breast cancer cells from blood samples using multi-orifice flow fractionation (MOFF) and dielectrophoresis (DEP). Lab Chip 11, 1118–1125 (2011).
  Article CAS PubMed Google Scholar
• Allard, W. J. et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin. Cancer Res. 10, 6897–6904 (2004).
  Article PubMed Google Scholar
• Riethdorf, S. et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin. Cancer Res. 13, 920–928 (2007).
  Article CAS PubMed Google Scholar
• Talasaz, A. H. et al. Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device. Proc. Natl Acad. Sci. USA 106, 3970–3975 (2009).
  Article PubMed PubMed Central Google Scholar
• Saucedo-Zeni, N. et al. A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire. Int. J. Oncol. 41, 1241–1250 (2012).
  PubMed PubMed Central Google Scholar
• Nagrath, S. et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450, 1235–1239 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Stott, S. L. et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc. Natl Acad. Sci. USA 107, 18392–18397 (2010).
  Article PubMed PubMed Central Google Scholar
• Ozkumur, E. et al. Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells. Sci. Transl. Med. 5, 179ra147 (2013).
  Article CAS Google Scholar
• Saliba, A. E. et al. Microfluidic sorting and multimodal typing of cancer cells in self-assembled magnetic arrays. Proc. Natl Acad. Sci. USA 107, 14524–14529 (2010).
  Article PubMed PubMed Central Google Scholar
• Zieglschmid, V. et al. Combination of immunomagnetic enrichment with multiplex RT-PCR analysis for the detection of disseminated tumor cells. Anticancer Res. 25, 1803–1810 (2005).
  CAS PubMed Google Scholar
• Harb, W. et al. Mutational analysis of circulating tumor cells using a novel microfluidic collection device and qPCR assay. Transl. Oncol. 6, 528–538 (2013).
  Article PubMed PubMed Central Google Scholar
• Vona, G. et al. Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer. Hepatology 39, 792–797 (2004).
  Article PubMed Google Scholar
• Hou, H. W. et al. Isolation and retrieval of circulating tumor cells using centrifugal forces. Sci. Rep. 3, 1259 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Alix-Panabieres, C. EPISPOT assay: detection of viable DTCs/CTCs in solid tumor patients. Recent Results Cancer Res. 195, 69–76 (2012).
  Article PubMed Google Scholar
• Lu, J. et al. Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients. Int. J. Cancer 126, 669–683 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• López-Riquelme, N. et al. Imaging cytometry for counting circulating tumor cells: comparative analysis of the CellSearch vs Image Stream systems. APMIS http://dx.doi.org/10.1111/apm.12061.
• Marrinucci, D. et al. Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers. Phys. Biol. 9, 016003 (2012).
  Article PubMed PubMed Central Google Scholar
• Kraan, J. et al. External quality assurance of circulating tumor cell enumeration using the CellSearch® system: a feasibility study. Cytometry B Clin. Cytom. 80, 112–118 (2011).
  Article PubMed Google Scholar
• Parkinson, D. R. et al. Considerations in the development of circulating tumor cell technology for clinical use. J. Transl. Med. 10, 138 (2012).
  Article PubMed PubMed Central Google Scholar
• Stathopoulou, A. et al. Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system. Clin. Cancer Res. 9, 5145–5151 (2003).
  CAS PubMed Google Scholar
• Xenidis, N. et al. Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer. J. Clin. Oncol. 27, 2177–2184 (2009).
  Article CAS PubMed Google Scholar
• Iinuma, H. et al. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer. J. Clin. Oncol. 29, 1547–1555 (2011).
  Article PubMed Google Scholar
• Chimonidou, M., Kallergi, G., Georgoulias, V., Welch, D. R. & Lianidou, E. S. Breast cancer metastasis suppressor-1 promoter methylation provides prognostic information in primary breast tumors. Mol. Cancer Res. 11, 1248–1257 (2013).
  Article CAS PubMed Google Scholar
• Chen, C. L. et al. Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer. Prostate 73, 813–826 (2013).
  Article CAS PubMed Google Scholar
• Fabbri, F. et al. Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs. Cancer Lett. 335, 225–231 (2013).
  Article CAS PubMed Google Scholar
• Peeters, D. J. et al. Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting. Br. J. Cancer 108, 1358–1367 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Punnoose, E. A. et al. Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib. Clin. Cancer Res. 18, 2391–2401 (2012).
  Article CAS PubMed Google Scholar
• Gasch, C. et al. Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer. Clin. Chem. 59, 252–260 (2013).
  Article CAS PubMed Google Scholar
• Voet, T. et al. Single-cell paired-end genome sequencing reveals structural variation per cell cycle. Nucleic Acids Res. 41, 6119–6138 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Dean, F. B. et al. Comprehensive human genome amplification using multiple displacement amplification. Proc. Natl Acad. Sci. USA 99, 5261–5266 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• De Roock, W. et al. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis. Lancet Oncol. 11, 753–762 (2010).
  Article CAS PubMed Google Scholar
• Klein, C. A. et al. Combined transcriptome and genome analysis of single micrometastatic cells. Nat. Biotechnol. 20, 387–392 (2002).
  Article CAS PubMed Google Scholar
• Ulmer, A. et al. Immunomagnetic enrichment, genomic characterization, and prognostic impact of circulating melanoma cells. Clin. Cancer Res. 10, 531–537 (2004).
  Article CAS PubMed Google Scholar
• Heitzer, E. et al. Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing. Cancer Res. 73, 2965–2975 (2013).
  Article CAS PubMed Google Scholar
• Powell, A. A. et al. Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines. PLoS ONE 7, e33788 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Cann, G. M. et al. mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer. PLoS ONE 7, e49144 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Asare, A. L. et al. Differential gene expression profiles are dependent upon method of peripheral blood collection and RNA isolation. BMC Genomics 9, 474 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Fidler, I. J. The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. Eur. J. Cancer 9, 223–227 (1973).
  Article CAS PubMed Google Scholar
• Liotta, L. A., Kleinerman, J. & Saidel, G. M. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res. 34, 997–1004 (1974).
  CAS PubMed Google Scholar
• Glaves, D. Correlation between circulating cancer cells and incidence of metastases. Br. J. Cancer 48, 665–673 (1983).
  Article CAS PubMed PubMed Central Google Scholar
• Liotta, L. A., Saidel, M. G. & Kleinerman, J. The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res. 36, 889–894 (1976).
  CAS PubMed Google Scholar
• Watanabe, S. The metastasizability of tumor cells. Cancer 7, 215–223 (1954).
  Article CAS PubMed Google Scholar
• Garvie, W. H. & Matheson, A. B. The effect of intravenous fluids on the development on experimental tumour metastases: their effect on tumour cell aggregation. Br. J. Cancer 20, 838–846 (1966).
  Article CAS PubMed PubMed Central Google Scholar
• Lione, A. & Bosmann, H. B. Quantitative relationship between volume of tumour cell units and their intravascular survival. Br. J. Cancer 37, 248–253 (1978).
  Article CAS PubMed PubMed Central Google Scholar
• Topal, B., Roskams, T., Fevery, J. & Penninckx, F. Aggregated colon cancer cells have a higher metastatic efficiency in the liver compared with nonaggregated cells: an experimental study. J. Surg. Res. 112, 31–37 (2003).
  Article CAS PubMed Google Scholar
• Knisely, W. H. & Mahaley, M. S. Jr. Relationship between size and distribution of spontaneous metastases and three sizes of intravenously injected particles of VX2 carcinoma. Cancer Res. 18, 900–905 (1958).
  CAS PubMed Google Scholar
• Thompson, S. C. The colony forming efficiency of single cells and cell aggregates from a spontaneous mouse mammary tumour using the lung colony assay. Br. J. Cancer 30, 332–336 (1974).
  Article CAS PubMed PubMed Central Google Scholar
• Edelman, G. M., Gallin, W. J., Delouvée, A., Cunningham, B. A. & Thiery, J. P. Early epochal maps of two different cell adhesion molecules. Proc. Natl Acad. Sci. USA 80, 4384–4388 (1983).
  Article CAS PubMed PubMed Central Google Scholar
• Kim, K. K. et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc. Natl Acad. Sci. USA 103, 13180–13185 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Kalluri, R. & Weinberg, R. A. The basics of epithelial–mesenchymal transition. J. Clin. Invest. 119, 1420–1428 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Kalluri, R. EMT: when epithelial cells decide to become mesenchymal-like cells. J. Clin. Invest. 119, 1417–1419 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Soltermann, A. et al. Prognostic significance of epithelial–mesenchymal and mesenchymal–epithelial transition protein expression in non-small cell lung cancer. Clin. Cancer Res. 14, 7430–7437 (2008).
  Article CAS PubMed Google Scholar
• Bellovin, D. I. et al. Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma. Oncogene 25, 6959–6967 (2006).
  Article CAS PubMed Google Scholar
• Gjerdrum, C. et al. Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival. Proc. Natl Acad. Sci. USA 107, 1124–1129 (2010).
  Article PubMed Google Scholar
• Otsuki, S. et al. Vimentin expression is associated with decreased survival in gastric cancer. Oncol. Rep. 25, 1235–1242 (2011).
  PubMed Google Scholar
• Lee, K. W. et al. Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition. Ann. Surg. Oncol. 19, 326–335 (2012).
  Article PubMed Google Scholar
• Byers, L. A. et al. An epithelial–mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin. Cancer Res. 19, 279–290 (2013).
  Article CAS PubMed Google Scholar
• Kurokawa, M., Ise, N., Omi, K., Goishi, K. & Higashiyama, S. Cisplatin influences acquisition of resistance to molecular-targeted agents through epithelial-mesenchymal transition-like changes. Cancer Sci. 104, 904–911 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Yauch, R. L. et al. Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients. Clin. Cancer Res. 11, 8686–8698 (2005).
  Article CAS PubMed Google Scholar
• Lim, S. et al. SNAI1-mediated epithelial-mesenchymal transition confers chemoresistance and cellular plasticity by regulating genes involved in cell death and stem cell maintenance. PLoS ONE 8, e66558 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Brabletz, T. et al. Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc. Natl Acad. Sci. USA 98, 10356–10361 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Stark, K., Vainio, S., Vassileva, G. & McMahon, A. P. Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 372, 679–683 (1994).
  Article CAS PubMed Google Scholar
• Hou, J. M. et al. Circulating tumor cells as a window on metastasis biology in lung cancer. Am. J. Pathol. 178, 989–996 (2011).
  Article PubMed PubMed Central Google Scholar
• Lecharpentier, A. et al. Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer. Br. J. Cancer 105, 1338–1341 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Kallergi, G. et al. Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients. Breast Cancer Res. 13, R59 (2011).
  Article PubMed PubMed Central Google Scholar
• Armstrong, A. J. et al. Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol. Cancer Res. 9, 997–1007 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Balasubramanian, P. et al. Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck. PLoS ONE 7, e42048 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Yu, M. et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339, 580–584 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 3983–3988 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Singh, S. K. et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 63, 5821–5828 (2003).
  CAS PubMed Google Scholar
• Ricci-Vitiani, L. et al. Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111–115 (2007).
  Article CAS PubMed Google Scholar
• Chan, K. S. et al. Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc. Natl Acad. Sci. USA 106, 14016–14021 (2009).
  Article PubMed PubMed Central Google Scholar
• Stewart, J. M. et al. Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells. Proc. Natl Acad. Sci. USA 108, 6468–6473 (2011).
  Article PubMed PubMed Central Google Scholar
• Reya, T., Morrison, S. J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature 414, 105–111 (2001).
  Article CAS PubMed Google Scholar
• Mani, S. A. et al. The epithelial–mesenchymal transition generates cells with properties of stem cells. Cell 133, 704–715 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Grimshaw, M. J. et al. Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells. Breast Cancer Res. 10, R52 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Fidler, I. J. Metastasis: quantitative analysis of distribution and fate of tumor embolilabeled with 125 I-5-iodo-2′-deoxyuridine. J. Natl Cancer Inst. 45, 773–782 (1970).
  CAS PubMed Google Scholar
• Luzzi, K. J. et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am. J. Pathol. 153, 865–873 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Chambers, A. F., Groom, A. C. & MacDonald, I. C. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2, 563–572 (2002).
  Article CAS PubMed Google Scholar
• Fidler, I. J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer 3, 453–458 (2003).
  Article CAS PubMed Google Scholar
• Chaffer, C. L. & Weinberg, R. A. A perspective on cancer cell metastasis. Science 331, 1559–1564 (2011).
  Article CAS PubMed Google Scholar
• Zhao, Q. et al. Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis. Mol. Cancer 9, 154 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Fidler, I. J. Immune stimulation-inhibition of experimental cancer metastasis. Cancer Res. 34, 491–498 (1974).
  CAS PubMed Google Scholar
• Ludatscher, R. M., Luse, S. A. & Suntzeff, V. An electron microscopic study of pulmonary tumor emboli from transplantable Morris hepatoma 5123. Cancer Res. 27, 1939–1952 (1967).
  CAS PubMed Google Scholar
• Sugino, T. et al. An invasion-independent pathway of blood-borne metastasis: a new murine mammary tumor model. Am. J. Pathol. 160, 1973–1980 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Küsters, B. et al. Micronodular transformation as a novel mechanism of VEGF-A-induced metastasis. Oncogene 26, 5808–5815 (2007).
  Article CAS PubMed Google Scholar
• Laübli, H., Stevenson, J. L., Varki, A., Varki, N. M. & Borsig, L. L-Selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest. Cancer Res. 66, 1536–1542 (2006).
  Article CAS PubMed Google Scholar
• Gasic, G. J., Gasic, T. B., Galanti, N., Johnson, T. & Murphy, S. Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease. Int. J. Cancer 11, 704–718 (1973).
  Article CAS PubMed Google Scholar
• Borsig, L., Wong, R., Hynes, R. O., Varki, N. M. & Varki, A. Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc. Natl Acad. Sci. USA 99, 2193–2198 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Upreti, M. et al. Tumor-endothelial cell three-dimensional spheroids: new aspects to enhance radiation and drug therapeutics. Transl. Oncol. 4, 365–376 (2011).
  Article PubMed PubMed Central Google Scholar
• Fidler, I. J. & Talmadge, J. E. Evidence that intravenously derived murine pulmonary melanoma metastases can originate from the expansion of a single tumor cell. Cancer Res. 46, 5167–5171 (1986).
  CAS PubMed Google Scholar
• Talmadge, J. E., Wolman, S. R. & Fidler, I. J. Evidence for the clonal origin of spontaneous metastases. Science 217, 361–363 (1982).
  Article CAS PubMed Google Scholar
• Krebs, M. G. et al. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches. J. Thorac. Oncol. 7, 306–315 (2012).
  Article PubMed Google Scholar
• Tomlinson, J. S., Alpaugh, M. L. & Barsky, S. H. An intact overexpressed E-cadherin/α, β-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma. Cancer Res. 61, 5231–5241 (2001).
  CAS PubMed Google Scholar
• Kleer, C. G., van Golen, K. L., Braun, T. & Merajver, S. D. Persistent E-cadherin expression in inflammatory breast cancer. Mod. Pathol. 14, 458–464 (2001).
  Article CAS PubMed Google Scholar
• Sugino, T. et al. Morphological evidence for an invasion-independent metastasis pathway exists in multiple human cancers. BMC Med. 2, 9 (2004).
  Article PubMed PubMed Central Google Scholar
• De Giorgi, U. et al. Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer. Ann. Oncol. 21, 33–39 (2010).
  Article CAS PubMed Google Scholar
• Cho, E. H. et al. Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors. Phys. Biol. 9, 016001 (2012).
  Article PubMed PubMed Central Google Scholar
• Griffiths, J. D., McKinna, J. A., Rowbotham, H. D., Tsolakidis, P. & Salsbury, A. J. Carcinoma of the colon and rectum: circulating malignant cells and five-year survival. Cancer 31, 226–236 (1973).
  Article CAS PubMed Google Scholar
• Hofman, V. et al. Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker. Clin. Cancer Res. 17, 827–835 (2011).
  Article CAS PubMed Google Scholar
• Kats-Ugurlu, G. et al. Circulating tumour tissue fragments in patients with pulmonary metastasis of clear cell renal cell carcinoma. J. Pathol. 219, 287–293 (2009).
  Article CAS PubMed Google Scholar
• Glaves, D., Huben, R. P. & Weiss, L. Haematogenous dissemination of cells from human renal adenocarcinomas. Br. J. Cancer 57, 32–35 (1988).
  Article CAS PubMed PubMed Central Google Scholar
• Brandt, B. et al. Isolation of prostate-derived single cells and cell clusters from human peripheral blood. Cancer Res. 56, 4556–4561 (1996).
  CAS PubMed Google Scholar
• Molnar, B., Ladanyi, A., Tanko, L., Sréter, L. & Tulassay, Z. Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients. Clin. Cancer Res. 7, 4080–4085 (2001).
  CAS PubMed Google Scholar
• Wang, Z. P. et al. Identification and characterization of circulating prostate carcinoma cells. Cancer 88, 2787–2795 (2000).
  Article CAS PubMed Google Scholar
• Krebs, M. G., Hou, J.-M., Ward, T. H., Blackhall, F. H. & Dive, C. Circulating tumour cells: their utility in cancer management and predicting outcomes. Ther. Adv. Med. Oncol. 2, 351–365 (2010).
  Article PubMed PubMed Central Google Scholar
• Gorges, T. M. & Pantel, K. Circulating tumor cells as therapy-related biomarkers in cancer patients. Cancer Immunol. Immunother. 62, 931–939 (2013).
  Article CAS PubMed Google Scholar
• Stott, S. L. et al. Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Sci. Transl. Med. 2, 25ra23 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Hiltermann, T. J. et al. Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor. Ann. Oncol. 23, 2937–2942 (2012).
  Article CAS PubMed Google Scholar
• Naito, T. et al. Prognostic impact of circulating tumor cells in patients with small cell lung cancer. J. Thorac. Oncol. 7, 512–519 (2012).
  Article PubMed Google Scholar
• Hayes, D. F. et al. Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin. Cancer Res. 12, 4218–4224 (2006).
  Article CAS PubMed Google Scholar
• Riethdorf, S. et al. Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial. Clin. Cancer Res. 16, 2634–2645 (2010).
  Article CAS PubMed Google Scholar
• de Bono, J. S. et al. Potential applications for circulating tumor cells expressing the insulin-like growth factor-I receptor. Clin. Cancer Res. 13, 3611–3616 (2007).
  Article CAS PubMed Google Scholar
• Liu, Z. et al. Eradication of EGFR-positive circulating tumor cells and objective tumor response with lapatinib and capecitabine. Cancer Biol. Ther. 10, 860–864 (2010).
  Article CAS PubMed Google Scholar
• Evans, W. K. et al. Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancer. J. Clin. Oncol. 3, 65–71 (1985).
  Article CAS PubMed Google Scholar
• Bidard, F. C. et al. Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials. Cancer Metastasis Rev. 32, 179–188 (2013).
  Article PubMed Google Scholar
• Swennenhuis, J. F., Tibbe, A. G., Levink, R., Sipkema, R. C. & Terstappen, L. W. Characterization of circulating tumor cells by fluorescence in situ hybridization. Cytometry A 75, 520–527 (2009).
  Article CAS PubMed Google Scholar
• Rossi, E. et al. M30 neoepitope expression in epithelial cancer: quantification of apoptosis in circulating tumor cells by CellSearch analysis. Clin. Cancer Res. 16, 5233–5243 (2010).
  Article CAS PubMed Google Scholar
• Ang, J. E., Kaye, S. & Banerji, U. Tissue-based approaches to study pharmacodynamic endpoints in early phase oncology clinical trials. Curr. Drug Targets 13, 1525–1534 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, L. H. et al. Monitoring drug-induced gammaH2AX as a pharmacodynamic biomarker in individual circulating tumor cells. Clin. Cancer Res. 16, 1073–1084 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Kallergi, G. et al. Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients. Breast Cancer Res. 10, R80 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Flores, L. M. et al. Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer. Br. J. Cancer 102, 1495–1502 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Kallergi, G. et al. Hypoxia-inducible factor-1α and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients. Breast Cancer Res. 11, R84 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Camidge, D. R. et al. Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study. Lancet Oncol. 13, 1011–1019 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Ilie, M. et al. ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma. Ann. Oncol. 23, 2907–2913 (2012).
  Article CAS PubMed Google Scholar
• Hayes, D. F. et al. Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer. Int. J. Oncol. 21, 1111–1117 (2002).
  CAS PubMed Google Scholar
• Jiang, Y., Palma, J. F., Agus, D. B., Wang, Y. & Gross, M. E. Detection of androgen receptor mutations in circulating tumor cells in castration-resistant prostate cancer. Clin. Chem. 56, 1492–1495 (2010).
  Article PubMed Google Scholar
• Leversha, M. A. et al. Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer. Clin. Cancer Res. 15, 2091–2097 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Liu, Y. et al. Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker. BMC Cancer 13, 202 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Crowley, E., Di Nicolantonio, F., Loupakis, F. & Bardelli, A. Liquid biopsy: monitoring cancer-genetics in the blood. Nat. Rev. Clin. Oncol. 10, 472–484 (2013).
  Article CAS PubMed Google Scholar
• De Mattos-Arruda, L. et al. Circulating tumour cells and cell-free DNA as tools for managing breast cancer. Nat. Rev. Clin. Oncol. 10, 377–389 (2013).
  Article CAS PubMed Google Scholar
• Dawson, S. J. et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N. Engl. J. Med. 368, 1199–1209 (2013).
  Article CAS PubMed Google Scholar
• Cristofanilli, M. & Fortina, P. Circulating tumor DNA to monitor metastatic breast cancer. N. Engl. J. Med. 369, 93–94 (2013).
  Article PubMed Google Scholar
• Taniguchi, K. et al. Quantitative detection of EGFR mutations in circulating tumor DNA derived from lung adenocarcinomas. Clin. Cancer Res. 17, 7808–7815 (2011).
  Article CAS PubMed Google Scholar
• Murtaza, M. et al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 497, 108–112 (2013).
  Article CAS PubMed Google Scholar
• Hofman, P. et al. Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinoma. Ann. Oncol. 23, 1738–1743 (2012).
  Article CAS PubMed Google Scholar
• Ni, X. et al. Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients. Proc. Natl Acad. Sci. USA 110, 21083–21088 (2013).
  Article CAS PubMed PubMed Central Google Scholar